GlaxoSmithKline PLC had 447 analyst reports since July 28, 2015 according to SRatingsIntel. The firm has …
GSK and Orchard will exchange manufacturing, technical and commercial insights and learnings on the development of …
The Nigerian Stock Exchange rebounded yesterday ... with a gain of 9.09 per cent to close at 96 kobo per share and GlaxosmithKline appreciated by 8.45 per cent …
GlaxoSmithKline plc (ADR) (NYSE:GSK) shares were soaring Friday as the company announced that it is no longer in the running to buy some of Pfizer Inc.’s (NYSE:PFE) assets. The company was considered to be the frontrunner to …
Shares of GlaxoSmithKline plc (GSK,GSK.L) were gaining around 6 percent in the morning trading in London after the British drug major announced Tuesday that it has reached an agreement to buyout Swiss drug maker Novartis' (NVS) …
LONDON (Reuters) - Britain’s Orchard Therapeutics, which has already raised more than $140 million (98.54 million pounds) to fund its work in gene therapy, plans another private sale of shares following its acquisition of a portfolio of …
Horlicks Ltd held 43.16% stake in GSK Consumer Healthcare Ltd as of December 2017, according to the Bombay Stock Exchange.\ GSK expects the outcome of the strategic review to be concluded around the end of 2018, the company …
The deal will have GlaxoSmithKline plc (ADR) buying Novartis’ 36.5% stake in the Consumer Healthcare Joint Venture. This will have GSK taking over full ownership of the Consumer Healthcare business. GlaxoSmithKline plc (ADR) says …